Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
- 1 March 2008
- journal article
- case report
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 57 (10) , 1429-1437
Abstract
NY-ESO-1 is a cancer/testis antigen highly immunogenic in cancer patients. Cholesterol-bearing hydrophobized pullulan (CHP) is a nanoparticle-forming antigen-delivery vehicle and CHP complexed with NY-ESO-1 protein (CHP-NY-ESO-1) efficiently activates CD4 and CD8 T cells in vitro.Keywords
This publication has 38 references indexed in Scilit:
- Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-primingProceedings of the National Academy of Sciences, 2007
- In vitroStimulation of CD8 and CD4 T Cells by Dendritic Cells Loaded with a Complex of Cholesterol-Bearing Hydrophobized Pullulan and NY-ESO-1 Protein: Identification of a New HLA-DR15–Binding CD4 T-Cell EpitopeClinical Cancer Research, 2006
- Recombinant NY‐ESO‐1 Cancer Antigen: Production and Purification under cGMP ConditionsPreparative Biochemistry & Biotechnology, 2005
- NY-ESO-1 Expression and Immunogenicity in Esophageal CancerClinical Cancer Research, 2004
- NY-ESO-1 Expression and Immunogenicity in Malignant and Benign Breast TumorsCancer Research, 2004
- NY‐ESO‐1 protein expression and humoral immune responses in prostate cancerThe Prostate, 2004
- Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenograftsin vivoInternational Journal of Cancer, 2000
- Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL-1αInternational Journal of Cancer, 2000
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Production of IL‐10 by melanoma cells: Examination of its role in immunosuppression mediated by melanomaInternational Journal of Cancer, 1994